PharmaBoardroom

ANMAT – Carlos Chiale, National Administrator –…

Carlos Chiale, National Administrator of ANMAT, discusses the agency’s latest strategy implementation and its pioneering work in the area of…

How Healthcare Works in the UAE

How quickly can a country truly transform its healthcare system, while making it sustainable for the future? The mindset of Emiratis is that anything…

Malaysian Medical Association – Dr. Krishna Kumar Hari…

MMA’s president shares the reasons why Malaysia is ranked today third in terms of healthcare quality, with a very efficient public system, high…

IMS Health – TK Koh, General Manager, Malaysia &…

IMS in Malaysia is possibly the first company to have signed a Memorandum of Understanding with the government for data provision. IMS Health’s…

Aspen Malaysia – Andrew Ooi, Country Manager

Aspen Malaysia’s country manager details the company’s success in the country with a specific business model based on acquiring and remarketing…

Sandoz Argentina – Mariano de Elizade, General Manager of…

The general manager of Sandoz South Latam weighs up the factors that have allowed his company to be the leader in biosimilars and differentiated…

Laboratorios Beta – Gregorio Zidar, Vice President –…

The vice president of Laboratorios Beta discusses the factors of why his organization is on the way to consolidating its different business lines…

Malaysia German Chamber of Commerce and Industry –…

MGCC’s Executive Director discusses the opportunities and challenges for German pharma and healthcare companies to invest in Malaysia, at a time…

Clinical Research Malaysia (CRM) – Dr. Mohamed Ali Abu…

Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of…

Scientific Technological Cabinet (GACTEC) – Alejandro…

The executive coordinator of GACTEC maps the current level of science and technology in Argentina and outlines the country’s ambitions in this…

IJN National Heart Institute – Tan Sri Dato’ Seri Dr.…

The National Heart Institute’s CEO portrays IJN as a national referral center for cardiovascular disease and declares: “IJN is equipped with the…

Level playing field: Chile aims for bioequivalence in 2014

Chile is aiming to achieve complete bioequivalence of generics by the end of 2014. Chile’s Public Health Institute is leading the bioequivalence…

Sign in

Tagged with